• 
  Cancers, Vol. 11, Pages 1517: Sorafenib-Regorafenib Sequential Therapy in Japanese Patients with Unresectable Hepatocellular Carcinoma—Relative Dose Intensity and Post-Regorafenib Therapies in Real World Practice

  Cancers, Vol. 11, Pages 1517: Sorafenib-Regorafenib Sequential Therapy in Japanese Patients with Unresectable Hepatocellular Carcinoma—Relative Dose Intensity and Post-Regorafenib Therapies in Real World Practice Cancers doi: 10.3390/cancers11101517 Authors: Wang Tsuchiya Kurosaki Yasui Inada Kirino Yamashita Sekiguchi Hayakawa Osawa Okada Higuchi Takaura Maeyashiki Kaneko Tamaki

  Cancers

  Tue Oct 08, 2019 17:00
• Cancers, Vol. 11, Pages 1516: Epidemiology of Simultaneous Medullary and Papillary Thyroid Carcinomas (MTC/PTC): An Italian Multicenter Study

  Cancers, Vol. 11, Pages 1516: Epidemiology of Simultaneous Medullary and Papillary Thyroid Carcinomas (MTC/PTC): An Italian Multicenter Study Cancers doi: 10.3390/cancers11101516 Authors: Marialuisa Appetecchia Rosa Lauretta Agnese Barnabei Letizia Pieruzzi Irene Terrenato Elisabetta Cavedon Caterina Mian Maria Grazia Castagna Rossella Elisei Background: The concomitant presence of papillary thyroid cancer (PT

  Cancers

  Tue Oct 08, 2019 17:00
• Cancers, Vol. 11, Pages 1514: KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy

  Cancers, Vol. 11, Pages 1514: KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy Cancers doi: 10.3390/cancers11101514 Authors: Ghimessy Gellert Schlegl Hegedus Raso Barbai Timar Ostoros Megyesfalvi Gieszer Moldvay Renyi-Vamos Lohinai Hoda Klikovits Klepetko Laszlo Dome

  Cancers

  Tue Oct 08, 2019 17:00
• Cancers, Vol. 11, Pages 1515: Gene-Specific Targeting of DNA Methylation in the Mammalian Genome

  Cancers, Vol. 11, Pages 1515: Gene-Specific Targeting of DNA Methylation in the Mammalian Genome Cancers doi: 10.3390/cancers11101515 Authors: Urbano Smith Weeks Chatterjee DNA methylation is the most widely-studied epigenetic modification, playing a critical role in the regulation of gene expression. Dysregulation of DNA methylation is implicated in the pathogenesis of numerous diseases. For example, aberrant DNA methyl

  Cancers

  Tue Oct 08, 2019 17:00
• Cancers, Vol. 11, Pages 1518: A Smo/Gli Multitarget Hedgehog Pathway Inhibitor Impairs Tumor Growth

  Cancers, Vol. 11, Pages 1518: A Smo/Gli Multitarget Hedgehog Pathway Inhibitor Impairs Tumor Growth Cancers doi: 10.3390/cancers11101518 Authors: Lospinoso Severini Quaglio Basili Ghirga Bufalieri Caimano Balducci Moretti Romeo Loricchio Maroder Botta Mori Infante Di Marcotullio : Pharmacological Hedgehog (Hh) pathway inhibition has emerged as a valuable anticancer strategy. A

  Cancers

  Tue Oct 08, 2019 17:00
• Cancers, Vol. 11, Pages 1513: Transcriptome Profiling Reveals Matrisome Alteration as a Key Feature of Ovarian Cancer Progression

  Cancers, Vol. 11, Pages 1513: Transcriptome Profiling Reveals Matrisome Alteration as a Key Feature of Ovarian Cancer Progression Cancers doi: 10.3390/cancers11101513 Authors: Sumegha Mitra Kartikeya Tiwari Ram Podicheti Taruni Pandhiri Douglas B. Rusch Andrea Bonetto Chi Zhang Anirban K. Mitra Background: Ovarian cancer is the most lethal gynecologic malignancy. There is a lack of comprehensive investigation of

  Cancers

  Tue Oct 08, 2019 17:00
• Cancers, Vol. 11, Pages 1511: Tumor Endothelial Heterogeneity in Cancer Progression

  Cancers, Vol. 11, Pages 1511: Tumor Endothelial Heterogeneity in Cancer Progression Cancers doi: 10.3390/cancers11101511 Authors: Nako Maishi Dorcas A. Annan Hiroshi Kikuchi Yasuhiro Hida Kyoko Hida Tumor blood vessels supply nutrients and oxygen to tumor cells for their growth and provide routes for them to enter circulation. Thus, angiogenesis, the formation of new blood vessels, is essential for tumor progression and m

  Cancers

  Tue Oct 08, 2019 17:00
• Cancers, Vol. 11, Pages 1512: Tumor Drug Distribution after Local Drug Delivery by Hyperthermia, In Vivo

  Cancers, Vol. 11, Pages 1512: Tumor Drug Distribution after Local Drug Delivery by Hyperthermia, In Vivo Cancers doi: 10.3390/cancers11101512 Authors: Helena C. Besse Angelique D. Barten-van Rijbroek Kim M.G. van der Wurff-Jacobs Clemens Bos Chrit T.W. Moonen Roel Deckers Tumor drug distribution and concentration are important factors for effective tumor treatment. A promising method to enhance the distribution and the

  Cancers

  Tue Oct 08, 2019 17:00